Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

By Donald E. Owens, Nicholas A. Peppas. International journal of pharmaceutics, 2006

3,500 citations recorded by the source corpus.

Subfields: Biomaterials, Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/9b2dc26d5f74751ce05806a8f3ae8697f87b4f0d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. S. Mitragotri
2. F. Danhier
3. O. Farokhzad
4. N. Bertrand
5. Robert Langer
6. Joerg Lahann
7. Xiaoyang Xu
8. V. Préat

In Physiology

1. S. Mitragotri
2. O. Farokhzad
3. N. Bertrand
4. Phatsapong Yingchoncharoen
5. D. Richardson
6. D. Kalinowski
7. A. Swami

In Pulmonary and Respiratory Medicine

1. Sanjiv Sam Gambhir
2. A. Nel
3. S. Mitragotri

Citations in the corpus

• Nanoparticle PEGylation for imaging and therapy (2011, background): “are also more vulnerable to the RES and hydrophilic PEG reduces these complications [22].”
• Understanding biophysicochemical interactions at the nano-bio interface. (2009, background): “Complement and immunoglobulin binding leads to particle opsonization: that is, it promotes receptor-mediated phagocytosi”
• Insight into nanoparticle cellular uptake and intracellular targeting (2014, neutral): “The soluble factors involved in the opsonization process include proteins of the complement system, antibodies, acetylcholine, laminin, fibronectin, C-reactive protein, and type-I collagen [29].”